News

New Research Grant Recipient Announced

January 11, 2018 | Categories: News, Research

In 2016, the Melanoma Research Foundation Breakthrough Consortium (MRFBC) convened a meeting of its scientific advisors to assess the greatest areas of need in the current research landscape to guide its grant funding. Following a thorough examination, the assembled researchers arrived at a consensus recommendation to encourage a critical mass of innovative young researchers to enter the promising field of melanoma immunotherapy.

The MRF Announces Kyleigh LiPira as CEO

January 9, 2018 | Categories: News

Today, the board of directors of the Melanoma Research Foundation announced Kyleigh LiPira, MBA as the MRF’s new Chief Executive Officer. LiPira was promoted from her position as Chief Development Officer.

January 2, 2018 | Categories: News, Research, Treatment

2017 Miles for Melanoma Top Fundraisers

December 19, 2017 | Categories: Events, News

As we cross the finish line for the 2017 season, the MRF's Miles for Melanoma team is reminded of the wonderful memories, powerful experiences and dedicated individuals and teams we met at events across the country this year. From Boston to San Diego, volunteer fundraisers came together to celebrate each other, honor loved ones and, most importantly, raise much-needed funds for life saving melanoma research. Below are the top individual and team fundraisers for each event:

Miles for Melanoma Boston

The MRF Welcomes CEO Elly Brtva

September 29, 2017 | Categories: News

The Board of Directors of the Melanoma Research Foundation (MRF) is excited to announce that Eleanor (Elly) Brtva will assume the role of CEO of the Melanoma Research Foundation, effective immediately. Elly brings a wealth of knowledge, experience and dedication to the MRF and we are eager to welcome her to the organization.

Congress Must Protect DoD Medical Research Funding

September 26, 2017 | Categories: News, Policy, Research

Since 1992, the Department of Defense Congressionally-Directed Medical Research Program (CDMRP) has transformed healthcare for service members and the American public through innovative and impactful biomedical research. As of 2017, Congress has, on a bipartisan basis, provided the CDMRP with $11.9 billion in funding to support high impact, high risk, and high gain projects that other agencies and private investors may be unwilling to fund.

Apply for the Medical Student Research Award

September 1, 2017 | Categories: News, Research

The Melanoma Reserach Foundation (MRF) is now accepting applications for the 2018 Medical Student Research Award. The MRF has been awarding this research grant since 2011 and in this time 35 grants have been awarded to students at 24 different institutions. The purpose of the Medical Student Research Award is to promote scientific inquiry and research opportunities to medical students early in their careers by funding concise clinical or laboratory-based research projects focused on better understanding the prevention, biology, and treatment of melanoma.

What's Next: 

FDA Expands Approval of Ipilimumab For Pediatric Melanoma Patients

August 3, 2017 | Categories: News, Research, Treatment

Last week the United States Food and Drug Administration (FDA) expanded approval of Yervoy (ipilimumab) to include pediatric patients ages 12 years and older with unresectable or metastatic melanoma. Yervoy, a monoclonal antibody that activates the immune system by blocking the CTLA-4 receptor, was first approved in 2011 to treat unresectable or metastatic melanoma in adults.

Indoor Tanning Association Ends Operations

August 2, 2017 | Categories: News, Policy, Prevention

Statement from the Melanoma Research Foundation

Update on the CURE OM Patient Registry

June 2, 2017 | Categories: News, Ocular Melanoma

“As a patient with choroidal melanoma with metastasis to liver, lymph node and brain, I want to share as much information as possible with other patients, researchers and clinical teams while I still can. They should have access to my story, my history, what has worked for me, what has not worked for me. We need to make headway in finding a cure so the next generation is not asking the same questions we are.

Pages